Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Colvin-Galloway Future band

This article was originally published in The Gray Sheet

Executive Summary

U.S. and European launch of the device, which is intended for use in heart valve repair, is announced by Medtronic Oct. 1. Implanted to support the posterior portion of the heart's mitral valve following surgical repair to correct stenosis or regurgitation, the C-G Future is semi-rigid, flexible and low-bulk, and has a profile 20% lower than other available semi-rigid devices, Medtronic claims. More than 90% of patients referred for mitral valve regurgitation underwent repair instead of valve replacement, and 95-99% experienced success, results of a recent study conducted at the Mayo Clinic show. The firm says more than 50,000 surgeries are performed annually worldwide to treat mitral valve insufficiency
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT015535

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel